HEALTH

NBTY picks up wealth of CPG experience with new senior level executives

BY Michael Johnsen

RONKONKOMA, N.Y. – NBTY on Thursday appointed four senior executives to its management team who will spearhead strategic growth initiatives for the company's branded businesses.
 
"NBTY's portfolio of brands is among the most well-known and trusted in the industry, and we're bringing in and promoting outstanding, experienced new talent that will drive our growth to the next level" stated Brian Wynne, president, NBTY Americas and CEO, US Nutrition. "These changes inject fresh thinking and perspective into the company while complementing our existing team of passionate and driven leaders."
 
Derek Bowen (pictured left) has been named SVP, general manager for vitamins, minerals, herbals and supplements. Bowen, who joins NBTY from Coty Beauty U.S., will be responsible for developing and executing strategic growth plans for all of NBTY's US Nutrition VMHS brands, including Nature's Bounty, Sundown Naturals, Osteo Bi-Flex and Ester-C, with full profit and loss accountability. As SVP marketing for Coty, Derek was responsible for managing volume and profit for the U.S. cosmetic and fragrance portfolios. Bowen has 20 years of experience in building and marketing well-known brands at consumer products companies such as Unilever, Sara Lee, Dial and P&G.
 
Bradley Charron (pictured right) was named SVP general manager for sports and active nutrition. Charron will be responsible for developing and executing strategic growth plans for all the company's sports and active nutrition brands, such as MET-Rx, Pure Protein, Body Fortress and Balance Bar, with full profit and loss accountability. Charron brings 15 years' experience with him to NBTY, most recently with Chobani, where he served as their SVP marketing. Prior to that, Charron held senior leadership positions with Under Armour, PepsiCo and Liz Claiborne.
 
Andre Branch has joined NBTY as chief marketing officer, where he will lead consumer and customer marketing efforts, as well as focus on strategies to further build NBTY's trusted and high-quality brands, including Nature's Bounty, Sundown Naturals, Ester-C, Solgar and Osteo Bi-Flex.  This will include developing the strategy, building brand and product roadmaps and developing a robust innovation pipeline that leverages consumer data, shopper insights and various media platforms. Branch brings more than 20 years of brand-building experience to the role from companies including Kraft Foods, Diageo and, most recently, L'Oreal.
 
Additionally, the company has promoted Jill Staib into a newly created position, VP strategic initiatives and private label. In this role she will focus on identifying and capturing value from both operational and market based opportunities and executing plans for NBTY's private label business, among other things.
 
 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

KT Tape names CEO

BY Antoinette Alexander

LINDON, UTAH — KT Health, parent company to KT Tape and a producer of kinesiology tape and related sports medicine products in the retail market, has named Greg Venner president and CEO.

John MacKay, KT Health’s outgoing CEO and one of the four original founders, will continue to remain actively involved in the company as a member of the board.  

Venner joins KT Health having spent his career building and leading enterprises and developing consumer brands in the sports nutrition, food, and consumer packaged goods sectors. Most recently, he was president and CEO of Dymatize Enterprises, a sports nutrition company. Prior to that he held key executive positions at such companies as Boulder Brands, Mead Johnson Nutritionals (a subsidiary of Bristol-Myers Squibb), Lance, Tropicana Products, and Conagra Frozen Foods.  

“The other founders and I have grown KT Health into the dominant player in the kinesiology tape category,” stated MacKay. “Greg’s expertise will take the company to its next stage of development and we are very excited that he is joining the team.” 

“I am thrilled to join KT Health and help build upon the incredible success John and his team have had,” stated Venner. “The opportunity to bring my experience building consumer brands to a market leader like KT is exciting.  My focus will be to continue to work with our retail partners to drive sales of KT Tape, grow internationally, and introduce new, innovative products to broaden the KT Health portfolio.”
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Cruex relaunched as a fungal nail revitalizing gel

BY Michael Johnsen

PHILADELPHIA – Ducere Pharma is relaunching Cruex as a fungal nail revitalizing gel, the company announced Tuesday.
 
"We are excited to be relaunching Cruex as a nail fungus gel,” said Ducere Pharma CEO Chris Dominello. Ducere Pharma conducted clinical research on Cruex in 2014 and 80% of users reported improvement in one week. The research found that the product reduced the discoloration of the affected nail and made the nail smoother after use. “With Cruex’s strong brand equity and superior claim, we believe this product will be a leader in the foot care category,” added Dominello.
 
Cruex Fungal Nail Revitalizing Gel, patented to improve the appearance of fungal nails, contains Bonicel – a purified filtrate produced by a probiotic called Ganeden BC. The product works topically and has been clinically proven to significantly improve the health and appearance of fungal nails.
 
Cruex, once manufactured by Novartis, was a popular jock-itch fighter. In 2013, Ducere Pharma bought Cruex and a number of other brands from Novartis.
 
Cruex will be available at retail beginning late April.
 
In addition to Cruex, Ducere Pharma also purchased Doan's for back pain, Comtrex for coughs and colds, Nupercainal for hemorrhoids, and Myoflex for muscle, joint and arthritis pain from Novartis.
 
“Our market research has shown that these products still have strong brand equity among consumers,” said Ducere Pharma director of marketing Lauren Schulz. “At Ducere Pharma, we aim to fill unmet needs under these established, trusted brand names. Finding new uses and creating new marketing campaigns is part of the plan.”
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?